Chronic Total Occlusion Devices Market Size is valued at USD 5.25 Bn in 2023 and is predicted to reach USD 8.22 Bn by the year 2031 at a 5.91% CAGR during the forecast period for 2024-2031.
CTO devices aim to facilitate the successful revascularization of these occluded arteries, restoring blood flow to the affected areas of the heart and improving patient outcomes. Chronic total occlusion (CTO) affects approximately one-third of patients undergoing angiography. A greater focus on enhancing the treatment of CTO could lead to a reduction in the number of bypass surgeries. Moreover, advancements in CTO device technology have resulted in the creation of innovative products boasting enhanced efficacy and safety characteristics. These devices provide minimally invasive treatment alternatives, thereby decreasing patient discomfort and shortening recovery periods compared to conventional surgical methods. Furthermore, heightened awareness among healthcare professionals regarding the advantages of CTO devices and their rising integration into clinical practice is propelling market growth. Physicians are increasingly acknowledging the significance of proficiently managing chronic total occlusions to enhance patient outcomes and minimize complication risks.
Furthermore, the expanding demand for interventional cardiology devices is expected to have a favourable impact on market growth. Coronary artery disease (CAD) remains highly prevalent, with an increasing number of patients affected by both CAD and peripheral artery disease (PAD). This trend is anticipated to drive the utilization of CTO treatments worldwide.
The market of chronic total occlusion devices is segmented on the basis of product type and end-users. The product type segment is categorized into microcatheters, guidewires, crossing devices, re-entry devices, and others. By end-use, the market is divided into hospitals & diagnostic centres, ambulatory care centres (ACC), and Others.
The. The Guidewires category is expected to hold a major share in the global Chronic Total Occlusion Devices market in 2022. Guidewires play a crucial role in navigating through complex coronary anatomy during CTO interventions. They are essential tools used by physicians to access and cross chronic total occlusions, facilitating the successful placement of stents or other interventional devices. Continuous advancements in guidewire technology have led to the development of innovative products with improved flexibility, steerability, and trackability. These advancements enhance the ability of physicians to navigate through challenging CTO lesions, increasing the success rates of procedures and driving demand for guidewires.
The Hospitals & Diagnostic Center segment is predicted to grow at a rapid rate in the global Chronic Total Occlusion Devices market. The expansion of hospitals and diagnostic centres equipped with advanced cardiac catheterization labs and interventional cardiology facilities increases accessibility to CTO interventions for patients. This expanded access allows more individuals with chronic total occlusions to undergo diagnostic procedures and receive appropriate treatment, driving demand for CTO devices. Hospitals and diagnostic centres often invest in state-of-the-art imaging technologies such as intravascular ultrasound (IVUS), optical coherence tomography (OCT), cardiac magnetic resonance imaging (MRI). These advanced diagnostic tools enable physicians to accurately assess the severity and complexity of CTO lesions, guiding treatment decisions and improving patient outcomes.
The North America Chronic Total Occlusion Devices market is expected to hold the highest market share. North America has a mature CTO devices market characterized by well-established healthcare infrastructure, advanced medical technologies, and high levels of awareness among healthcare professionals and patients. In addition, Asia Pacific is estimated to grow at a rapid rate in the global Chronic Total Occlusion Devices market. The region is a center for medical innovation and research, where universities, hospitals, and business leaders work together to create and assess novel CTO tools, methods, and therapeutic approaches.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 5.25 Bn |
|
Revenue Forecast In 2031 |
USD 8.22 Bn |
|
Growth Rate CAGR |
CAGR of 5.91% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type And End-User. |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Medtronic, Boston Scientific Corporation, Terumo Europe, Cordis Corporation, Spectranetics, IntraLuminal Therapeutics, Bard Peripheral Vascular, Baylis Medical Company, Inc., and Soundbite Medical Solutions Acrostak Int. Distr. Sarl, Abbott, Asahi Intecc Co., Ltd., Cardinal Health, Cook Medical, Merit Medical Systems, Koninklijke Philips N.V., Penumbra, Inc., Reflow Medical, Teleflex Incorporated, Becton, Dickinson and Company, others |
|
Customization Scope |
Free?customization?report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Chronic Total Occlusion Devices Market Snapshot
Chapter 4. Global Chronic Total Occlusion Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. Microcatheters
5.2.2. Guidewires
5.2.3. Balloon Catheters
5.2.4. Crossing Devices
5.2.5. Stents
5.2.6. Others
Chapter 6. Market Segmentation 2: by End-User Estimates & Trend Analysis
6.1. by End-User & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-User:
6.2.1. Hospitals
6.2.2. Ambulatory Surgical Centers
6.2.3. Others
Chapter 7. Chronic Total Occlusion Devices Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Chronic Total Occlusion Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
7.1.2. North America Chronic Total Occlusion Devices Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
7.1.3. North America Chronic Total Occlusion Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.2. Europe
7.2.1. Europe Chronic Total Occlusion Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
7.2.2. Europe Chronic Total Occlusion Devices Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
7.2.3. Europe Chronic Total Occlusion Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Chronic Total Occlusion Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
7.3.2. Asia Pacific Chronic Total Occlusion Devices Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
7.3.3. Asia Pacific Chronic Total Occlusion Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.4. Latin America
7.4.1. Latin America Chronic Total Occlusion Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
7.4.2. Latin America Chronic Total Occlusion Devices Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
7.4.3. Latin America Chronic Total Occlusion Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Chronic Total Occlusion Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2019-2031
7.5.2. Middle East & Africa Chronic Total Occlusion Devices Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
7.5.3. Middle East & Africa Chronic Total Occlusion Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Medtronic
8.2.2. Boston Scientific Corporation
8.2.3. Terumo
8.2.4. Cordis Corporation
8.2.5. Spectranetics
8.2.6. IntraLuminal Therapeutics
8.2.7. Bard Peripheral Vascular
8.2.8. Baylis Medical Company, Inc
8.2.9. Soundbite Medical Solutions
8.2.10. Acrostak Int. Distr. Sarl
8.2.11. Abbott
8.2.12. Asahi Intecc Co., Ltd.
8.2.13. Cardinal Health
8.2.14. Cook Medical
8.2.15. Merit Medical Systems
8.2.16. Koninklijke Philips N.V.
8.2.17. Penumbra, Inc.
8.2.18. Reflow Medical
8.2.19. Teleflex Incorporated
8.2.20. Becton, Dickinson and Company
8.2.21. Other Prominent Players
Chronic Total Occlusion Devices Market By Product
Chronic Total Occlusion Devices Market By End-Use
Chronic Total Occlusion Devices Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
